Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Incyte/Vysis/Genome Systems

Executive Summary

Incyte/Vysis/Genome Systems: Enter three-year collaboration to develop comprehensive genomic map that identifies chromosomal locations for human gene sequences. Palo Alto, Calif.-based Incyte will provide its proprietary DNA clones of expressed gene sequences; Genome Systems of St. Louis will map the gene sequences against their bacterial artificial chromosome library; and Downers Grove, Ill.-based Vysis physically will locate and map the genes to their chromosome locations using their Fluorescence In-Situ Hybridization technology. Incyte also announces it is acquiring Genome Systems, including Vysis' equity position in the company...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028597

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel